Zentek Ltd.

NASDAQ:ZTEK

Other Precious Metals

Basic Materials
$0.49 +25.56%

+$0.10 today

Market cap
$62.30M
Beta
0.47
P/E (TTM)
-9.6
EPS (TTM)
-$0.08
52W Low $0.37High $1.34

Volume 0.93M

Average 0.15M

ZTEK Other Financing Activities

Financing cash flows not reported separately.

Zentek Ltd.NASDAQ: ZTEK

Other Financing Activities · Q4 FY2025 · quarter ended Mar 2026

Other financing activities declines year over year

Q4 FY2025 other financing activities of CA$45.31K (cash outflow) fell 17.6% year over year, ahead of the -59.8% change in trailing-twelve-month other financing activities.

Context

  • Other financing activities amounted to 103.6% of revenue in FY2025, up 101.7 pp from a year earlier.
  • Other financing activities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -17.6% holds above the trailing-twelve-month pace of -59.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$45.31K-125950.0% QoQ
Last fiscal yearMar 2026
-CA$172.43K-1177.0% YoY
LTMMar 2026
-CA$35.59K-59.8% YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-17.6%——
1 year-1177.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Financing Activities history

CAD · from the cash flow

Latest · FY2025
(172.43K) CAD
Year-over-year change
-1177.0%

Other Financing Activities vs competitors

How ZTEK compares with its peers on the latest reported figures

  • Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -59.8% is the 4th highest of 7, against a peer median of -52.1%.
  • Other financing activities amounts to 21.4% of revenue for ZTEK, versus a peer median of 0.1%.
ZTEK Competitors
Other Financing Activities for ZTEK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$15.6M CAD-17.0%+40322751.6%—
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$360.02K CAD+32.9%—2.0%
AMWLAmerican Well CorporationLTM Mar 2026$300K USD-87.3%—0.1%
BYSIBeyondSpring Inc.LTM Mar 2026$283.51K USD———
ZTEKZentek Ltd.LTM Mar 2026CA$35.59K CAD-59.8%—21.4%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$1K USD-100.0%——
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD+100.0%——
HYPRHyperfine, Inc.LTM Mar 2026$0 USD-100.0%—0.0%
MBOTMicrobot Medical Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding ZTEK) —-52.1%+40322751.6%0.1%

Competitors are the stored peer set for ZTEK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Net Income(12.02M)(14.41M)(8.64M)(10.04M)(9.79M)
Depreciation & Amortization614.71K539.69K453.04K600.32K527.77K
Deferred Income Tax0(808.08K)000
Stock-Based Compensation4.73M3.2M01.53M0
Change in Working Capital(1.36M)(2.4M)675.37K1.48M1.5M
Accounts Receivables(536.82K)(12.84K)201.14K(906.22K)833.64K
Inventory(665.57K)(2.18M)(51.86K)397.48K168.74K
Accounts Payables831.48K000406.52K
Other Working Capital(985.52K)(198.98K)526.09K1.98M92.57K
Other Non-Cash Items48.12K917.7K1.57M150.99K2.68M
Operating Cash Flow(7.99M)(12.96M)(5.94M)(6.28M)(5.08M)
Capital Expenditures(3.99M)(2.27M)(236.3K)(1.4K)(2.03K)
Acquisitions (Net)007.38K02.38M
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.27M)(33.64K)1.82M360.05K0
Investing Cash Flow(7.25M)(2.31M)1.39M358.65K1.67M
Debt Repayment(122.45K)(1.1M)(177.43K)(562.11K)1.63M
Common Stock Issued35.34M083.42K3.07M3.13M
Common Stock Repurchased00(301.82K)00
Dividends Paid00000
Other Financing Activities3.6M46K(95.42K)16.01K(172.43K)
Financing Cash Flow38.82M(1.05M)(491.25K)2.52M4.59M
Effect of Forex Changes005.31M04.08K
Net Change in Cash23.58M(16.32M)268.59K(3.4M)1.19M
Free Cash Flow(11.97M)(15.23M)(6.18M)(6.28M)(5.08M)

Zentek Ltd.

NASDAQ:ZTEK

Intrinsic Alpha fair value

Locked

Current Price

$0.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.